MIT Optimal Sourcing Solutions
MIT Optimal Sourcing Solutions is a dedicated supplier of comparator drugs, specialised in European Union...
Read More...
Focus:
Netherlands
-
![]()
InflaRx starts dosing Covid-19 patients in Europe
German biopharmaceutical firm InflaRx has enrolled and dosed the first patient in a clinical study...
Read More...
-
![]()
ProQR doses first patient in Aurora trial of retinal disease therapy
ProQR Therapeutics has dosed the first patient in a Phase I/II Aurora clinical trial to...
Read More...
-
Gilead and Galapagos report data from filgotinib trials in RA
US antiviral drugmaker Gilead Sciences and Belgo-Dutch biotech Galapagos have announced week 52 data from...
Read More...
-
![Controlled trial offers hope for restoring vision in LSCD patients]()
ProQR to study new drug candidate for retinitis pigmentosa
ProQR Therapeutics has announced plans to conduct a Phase I/II clinical trial to evaluate QR-1123...
Read More...
-
![Controlled trial offers hope for restoring vision in LSCD patients]()
ProQR commences treatment in sepofarsen’s Phase II/III trial
Dutch biotech firm ProQR Therapeutics has started dosing patients in a Phase II/III clinical trial...
Read More...
-
Deals this week: Argenx, SmartZyme BioPharma, Viracta Therapeutics
Argenx will develop and license its cancer drug candidate cusatuzumab (ARGX-110) after partnering with Janssen Pharmaceutical’s affiliate...
Read More...
-
Deals this week: AgaMatrix, Kissei Pharmaceutical, 89Bio
Arcadia Group is to use AgaMatrix's blood glucose monitoring (BGM) technology for diabetes products marketed under the...
Read More...
-
Deals and M&As this week: CRISPR, Integral Molecular, Evotec
CRISPR Therapeutics and ViaCyte have formed a strategic collaboration to develop gene-edited, stem cell-derived therapies...
Read More...
-
argenx begins dosing in Phase III myasthenia gravis trial
Biotechnology company argenx has started dosing patients in a Phase III clinical trial of its...
Read More...